Synokem Pharma

Delhi, India Founded: 1983 • Age: 43 yrs Acquired By TA
Generic drugs are manufactured by Synokem Pharma in Delhi.

About Synokem Pharma

Synokem Pharma is a Healthcare company based in Delhi (India) founded in 1983, and was acquired by TA in January 2023. Generic drugs are manufactured by Synokem Pharma in Delhi. The company has 363 employees. Synokem Pharma has completed 1 acquisition, including Nitin Lifesciences. Its Indian entity Synokem Pharmaceuticals Limited reported revenue of β‚Ή556 Cr. Its focus areas include Traditional Pharmaceuticals, Generics and Diversified.

Company details

Synokem Pharma was established in 1983 in Delhi, India, within the pharmaceutical sector. Generic drugs are produced by the company as affordable alternatives to branded medications. Manufacturing operations are centered in India, emphasizing quality standards for therapeutic products. The focus remains on domestic supply, with potential outreach to international markets through established channels. Details are accessible via the domain synokempharma.com.

  • Headquarters Delhi, India
  • Employees 363
  • Stage Acquired
  • Sectors
    Healthcare
  • Website category Health · Biotechnology and Pharmaceuticals
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website synokempharma.com
  • Social LinkedIn X Facebook Instagram
  • Acquired by TA (Jan 2023)
  • Legal Name Synokem Pharmaceuticals Ltd
  • Date of Incorporation 18 Aug, 1983
  • Jurisdiction New Delhi, Delhi, India
Key Metrics
  • Annual Revenue
    ₹556 Cr

    FY 2025 · 0% YoY

  • Net Loss
    -₹3.28 Cr

    FY 2025 · 0% margin

  • EBITDA
    ₹31.90 Cr

    FY 2025 · 4% margin

  • Investors
  • Employee Count
    363
  • Investments & Acquisitions
  • Acquired by
    TA

    (Jan 2023)

Investors in Synokem Pharma

Synokem Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TA Associates.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Multiple sectors are invested in by private equity firm TA.
ta.comBoston, United States
Premium access

Investor details for Synokem Pharma

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Synokem Pharmaceuticals Limited (Synokem Pharma)

Synokem Pharmaceuticals Limited is the primary company behind Synokem Pharma. The board of Synokem Pharmaceuticals Limited currently have 8 directors; the longest-serving is Abhinav Arora, appointed in 2005. 18 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Abhinav Arora
DIN 00154626
Managing Director01 Jul 200521 yrs 3 moSynokem Pharmaceuticals Limited
Thomas Baby
DIN 03403531
Director01 Jul 20197 yrs 3 moSynokem Pharmaceuticals Limited
Sanjay Khurana
DIN 01055040
Director10 Jan 20224 yrs 9 moSynokem Pharmaceuticals Limited
Shubhangi Agarwal
DIN 08135535
Director01 Apr 20224 yrs 6 moSynokem Pharmaceuticals Limited
Vishal Gupta
DIN 09442347
Nominee Director18 Jan 20233 yrs 9 moSynokem Pharmaceuticals Limited
Gajanan Mohan Shenoy
DIN 10561178
Director30 Mar 20242 yrs 6 moSynokem Pharmaceuticals Limited
Dhiraj Poddar
DIN 01946905
Nominee Director24 Jul 20242 yrs 2 moSynokem Pharmaceuticals Limited
Yugal Kishor Chothuram Sikri
DIN 07576560
Nominee Director31 Jan 20268 moSynokem Pharmaceuticals Limited

Financials of Synokem Pharma

Figures of Synokem Pharmaceuticals Limited, the primary company behind Synokem Pharma, for FY 2025. Revenue was ₹556 Cr (0% year on year). Net loss was -₹3.28 Cr (0% margin). EBITDA was ₹31.90 Cr (4% margin). Revenue has grown at a compounded annual rate of +5% over three years.

  • ₹556 CrRevenue · FY 2025 · 0% YoY
  • -₹3.28 CrNet loss · 0% margin
  • ₹31.90 CrEBITDA · 4% margin
  • ₹4.82 CrPaid-up capital
  • 363Employees (provident fund records)
  • +5%Revenue CAGR, 3 years

Balance sheet, profit and loss, cash flow and ratios of Synokem Pharmaceuticals Limited are on its company page.

Premium access

Detailed financial statements for Synokem Pharma

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Synokem Pharma

Synokem Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Nitin Lifesciences.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
CMO of small volume parenteral injectables
nitinlifesciences.comKarnal, India1994Oct 2023β€’β€’β€’β€’
Premium access

Complete acquisition details for Synokem Pharma

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of Synokem Pharma

3 dated milestones of Synokem Pharma across 40 years, from founding to its latest funding, stage changes and deals.

  1. Founded Synokem Pharma is founded.
  2. Exit Acquired by TA.
  3. Acquisition Acquires Nitin Lifesciences.

Web traffic of Synokem Pharma

The website of Synokem Pharma (synokempharma.com) receives about 1.8K visits a month and ranks #7,667,368 among all websites worldwide, #7,107 in Biotechnology and Pharmaceuticals.

  • Monthly visits
    1.8K

    ▲ 17.6% vs previous month

  • Global rank
    #7,667,368

    among all websites

  • Category rank
    #7,107

    Health · Biotechnology and Pharmaceuticals

Similar websites

Websites whose visitors overlap most with Synokem Pharma. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
alcheminternational.com
100%
13.4K#6,011,638View details
baxter.in
baxter.in
91%
#1,654,418–
zyduscadila.com
87%
25.8K#1,058,292View details
cironpharma.com
82%
2.4K#7,858,699View details
atriabph.com
atriabph.com
81%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 19 similar websites and full traffic analytics for Synokem Pharma

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 19 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Traditional Health & Nutrition

3 companies that operate in the same segment as Synokem Pharma (Traditional Health & Nutrition) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Oral solid drug delivery systems are manufactured and developed.
1985Mumbai, Maharashtra, IndiaUSD 42.49 MUSD 89.42 M962
Generic, semi-solid, and liquid dosage forms are manufactured.
1990Bengaluru, Karnataka, IndiaUSD 508.93 M5,180
Specialty generic pharmaceuticals and APIs are manufactured and marketed.
1983Mumbai, Maharashtra, IndiaUSD 6.21 B25,870
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Synokem Pharma

Synokem Pharma was founded in 1983.

Synokem Pharma is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Synokem Pharma has 363 employees.

The primary company behind Synokem Pharma, Synokem Pharmaceuticals Limited, reported revenue of β‚Ή556 Cr for FY 2025, down 0% year on year.

Synokem Pharma was established in 1983 in Delhi, India, within the pharmaceutical sector. Generic drugs are produced by the company as affordable alternatives to branded medications. Manufacturing operations are centered in India, emphasizing quality standards for therapeutic products. The focus remains on domestic supply, with potential outreach to international markets through established channels. Details are accessible via the domain synokempharma.com.

Synokem Pharma has made 1 acquisition, including Nitin Lifesciences.

Synokem Pharma has 1 investor. Key investors include TA Associates.

Synokem Pharma operates through Synokem Pharmaceuticals Limited.

Yes. Synokem Pharma was acquired by TA in January 2023.

The legal entities of Synokem Pharma currently have 9 directors, including Gajanan Mohan Shenoy, Vishal Gupta, Abhinav Arora and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available